HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabrice Margaron Selected Research

Retinal Vein Occlusion

7/2009Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabrice Margaron Research Topics

Disease

1Retinal Vein Occlusion
07/2009
1Lyme Disease (Disease, Lyme)
05/2008
1Infections
04/2002

Drug/Important Bio-Agent (IBA)

1Tissue Plasminogen Activator (Alteplase)FDA Link
07/2009
1FlagellinIBA
05/2008
1DNA (Deoxyribonucleic Acid)IBA
04/2002

Therapy/Procedure

1Hemodilution
07/2009
1Thrombolytic Therapy
07/2009